Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000002236 | SCV004201516 | likely pathogenic | Peroxisome biogenesis disorder 7A (Zellweger) | 2023-02-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005222658 | SCV005863435 | pathogenic | Peroxisome biogenesis disorder 7A (Zellweger); Peroxisome biogenesis disorder 7B | 2024-02-13 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 89 of the PEX26 protein (p.Gly89Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Zellweger syndrome (PMID: 12851857). ClinVar contains an entry for this variant (Variation ID: 2153). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PEX26 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects PEX26 function (PMID: 12851857). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000002236 | SCV000022394 | pathogenic | Peroxisome biogenesis disorder 7A (Zellweger) | 2003-08-01 | no assertion criteria provided | literature only |